Abstract
Although pulmonary vascular abnormalities in pulmonary hypertension vary with different etiologies and with the vascular segments affected, many of the structural changes are similar, since they reflect the limited ways in which the vasculature of the lung either adapts to the elevated blood pressure or repairs hypertension-induced vessel damage. The purpose of this chapter is to provide the general histopathological characteristics of hypertensive pulmonary vascular disease as a framework for analyzing pathological material from patients with this condition, to present information regarding the pathology of the more commonly recognized forms of pulmonary hypertension, and to offer recommendations for the optimal handling of lung samples. The histopathological classification of hypertensive vascular disease used in this chapter is summarized in Table 1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarons EJ, Nye FJ (1991) Primary pulmonary hypertension and HIV infection. AIDS 5:1276–1277
Abenhaim L, Moride Y, Brenot F, et al (1996) Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International primary pulmonary hypertension study group. N Engl J Med 335:609–616
Bjornsson J, Edwards WD (1985) Primary pulmonary hypertension: a histopathologic study of 80 cases. Mayo Clin Proc 60:16–25
Burke AP, Farb A, Virmani R (1991) The pathology of primary pulmonary hypertension. Mod Pathol 4:269–282
Davies PF (1997) Overview: temporal and spatial relationships in shear stress-mediated endothelial signaling. J Vasc Res 34:208–211
Fuster V, Steele PM, Edwards WD, et al (1984) Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70:580–587
Garcia-Dorado D, Miller DD, Garcia EJ, et al (1983) An epidemic of pulmonary hypertension after toxic rapeseed oil ingestion in Spain. J Am Coll Cardiol 1:1216–1222
Gurtner HP, Gertsch M, Salzmann C, et al (1968) Häufen sich die primär vasculären Formen des chronischen Cor pulmonale? Schweiz Med Wochenschr 98:1579–1589, 1695–1707
Gurubhagavatula I. Palevsky HI (1997) Pulmonary hypertension in systemic autoimmune disease. Rheum Dis Clin North Am 23:365 – 394
Haraida S, Lochbühler H, Heger A, et al (1997) Congenital alveolar capillary dysplasia: rare cause of persistent pulmonary hypertension. Pediatr Pathol Lab Med 17:959–975
Haworth SG, Rabinovitch M, Meyrick B, et al (1988) Pathologic interpretation and classification of pulmonary hypertension. In: Rich S (ed) Executive summary. World symposium — primary pulmonary hypertension, Evian, France
Heath D, Edwards JE (1958) The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 18:533–547
Hervé P, Lebrec D, Brenot F, et al (1998) Pulmonary vascular disorders in portal hypertension. Eur Respir J 11:1153–1166
Heymann MA, Soifer SJ (1990) Persistent pulmonary hypertension of the newborn. In: Fishman AP (ed) The pulmonary circulation: normal and abnormal. Mechanisms, management, and the National Registry. University of Philadelphia Press, Philadelphia, chap 27, pp 372–383
Jamison BM, Michel RP (1995) Different distribution of plexiform lesions in primary and secondary pulmonary hypertension. Hum Pathol 26:987–993
Kim KK, Factor SM (1987) Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome. Hum Pathol 18: 1293–1296
Langleben D, Henegan J, Batten AP (1988) Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. Ann Intern Med 109:106–109
Langston C (1991) Misalignment of pulmonary veins and alveolar capillary dysplasia. Pediatr Pathol 11:163–170
Lee SD, Shroyer KR, Markham NE, et al (1998) Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 101:927–934
Levin DL, Weinberg AG, Perkin RM (1983) Pulmonary microthrombi syndrome in newborn infants with unresponsive persistent pulmonary hypertension. J Pediatr 102:299–303
Loyd JE, Atkinson JB, Pietra GG, et al (1988) Heterogeneity of pathologic lesions in familial primary pulmonary hypertension. Am Rev Respir Dis 138:952–957
Magee F, Wright JL, Kay MJ, et al (1985) Pulmonary capillary hemangiomatosis. Am Rev Respir Dis 132:922–925
Mark EJ, Patalas ED, Chagn HT, et al (1997) Fatal pulmonary hypertension associated with short-term use of fenfluramine and phen-termine. N Engl J Med 337:602–606
Martinez Tello FJ, Navas Palacios JJ, Ricoy JR, et al (1982) Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain. Virchows Arch (A) 397:261–285
Mette SA, Palevsky HI, Pietra GG, et al (1992) Primary pulmonary hypertension in association with human immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive arteriopathy. Am Rev Respir Dis 145:1196–1200
Morris W, Knauer CM (1997) Cardiopulmonary manifestations of schistosomiasis. Semin Respir Infect 12:159–170
Opravil M, Pechère M, Speich R, et al (1997) HIV-associated primary pulmonary hypertension. A case control study. Am J Respir Crit Care Med 155:990–995
Pietra GG (1997) The pathology of primary pulmonary hypertension. In: Rubin LJ, Rich S (eds) Primary pulmonary hypertension. Dekker, New York, chap 2, pp 19–62
Pietra GG, Edwards WD, Kay JM, et al (1989) Histopathology of pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 80:1198–1206
Rabinovitch M (1999) Pulmonary hypertension: pathophysiology as a basis for clinical decision-making. J Heart Lung Transplant 18: 1041–1053
Rich S, McLaughlin W (1999) The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. J Am Coll Cardiol 34:1184–1187
Ruchelli ED, Nojadera G, Rutstein RM, et al (1994) Pulmonary veno-occlusive disease: another vascular disorder associated with human immunodeficiency virus infection? Arch Pathol Lab Med 118:664–666
Ungerer RG, Tashkin DP, Furst D, et al (1983) Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 75:65–74
Wagenvoort CA (1990) Pulmonary veno-occlusive-disease. In: Fish-man AP (ed) The pulmonary circulation: normal and abnormal. Mechanisms, management, and the National Registry. University of Philadelphia Press, Philadelphia, chap 24, pp 343–352
Wagenvoort CA, Wagenvoort N (1977) Pathology of pulmonary hypertension. Wiley, New York
Widgren S, Kapanci Y (1970) Menocilbedingte pulmonale Hypertonic Vorläufige morphologische Ergebnisse über 8 pathologischanatomisch untersuchte Fälle. Z Kreislauf Forsch 59:924–930
Yuhan XJ, Wang J, Juhaszova M, et al (1998) Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet 351: 726–727
Yousem SA (1990) The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol 21:467–474
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pietra, G.G., Dessy, E. (2002). Hypertensive Pulmonary Vasculopathies: Pathological Findings. In: Lanzer, P., Topol, E.J. (eds) Pan Vascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56225-9_101
Download citation
DOI: https://doi.org/10.1007/978-3-642-56225-9_101
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62565-7
Online ISBN: 978-3-642-56225-9
eBook Packages: Springer Book Archive